Related references
Note: Only part of the references are listed.Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling
Sina Barysch et al.
EMBO REPORTS (2021)
Interferon regulatory factor 2 binding protein 2b regulates neutrophil versus macrophage fate during zebrafish definitive myelopoiesis
Luxiang Wang et al.
HAEMATOLOGICA (2020)
The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice
Xue Feng et al.
HEPATOLOGY (2020)
Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells
Hasan Onur Caglar et al.
MOLECULAR BIOLOGY REPORTS (2020)
Interferon Regulatory Factor-2 Binding Protein 2 Ameliorates Sepsis-Induced Cardiomyopathy via AMPK-Mediated Anti-Inflammation and Anti-Apoptosis
Tianyu Li et al.
INFLAMMATION (2020)
Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy
Wei Wang et al.
CELLS (2020)
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression
Jichao He et al.
ONCOGENE (2020)
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
Ying-Hsia Chu et al.
MODERN PATHOLOGY (2020)
IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling
A. B. M. Kaiser Manjur et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor
Yangyang Yao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review
Yiping Liu et al.
ONCOTARGETS AND THERAPY (2019)
Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non-small-cell Lung Cancer
Buhai Wang et al.
CLINICAL LUNG CANCER (2019)
Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion
Ailing Wu et al.
EMBO JOURNAL (2019)
The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation
Inyoung Kim et al.
BMB REPORTS (2019)
IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid
Samir Mazharuddin et al.
LEUKEMIA & LYMPHOMA (2018)
Interplay between inflammatory tumor microenvironment and cancer stein cells (Review)
Shijian Zhang et al.
ONCOLOGY LETTERS (2018)
The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia
J. V. Jovanovic et al.
LEUKEMIA (2017)
Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury
Shelly A. Cruz et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
IRF2BP2-deficient microglia block the anxiolytic effect of enhanced postnatal care
Aswin Hari et al.
SCIENTIFIC REPORTS (2017)
New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion
Yoshimitsu Shimomura et al.
CANCER SCIENCE (2016)
IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering
Cristiane Secca et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
R. Dixon Dorand et al.
SCIENCE (2016)
IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis
Hsiao-Huei Chen et al.
CIRCULATION RESEARCH (2015)
Identification of a Novel Fusion Gene, IRF2BP2-RARA, in Acute Promyelocytic Leukemia
C. Cameron Yin et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Control of developmentally primed erythroid genes by combinatorial co-repressor actions
Ralph Stadhouders et al.
NATURE COMMUNICATIONS (2015)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Chromatin modifiers and remodellers: regulators of cellular differentiation
Taiping Chen et al.
NATURE REVIEWS GENETICS (2014)
PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
Hatem Soliman et al.
PLOS ONE (2014)
Mutational analysis of primary central nervous system lymphoma
Aurelie Bruno et al.
ONCOTARGET (2014)
Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma
Kaja B. Nyquist et al.
PLOS ONE (2012)
Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study
Ivyna Bong Pau Ni et al.
HEMATOLOGY REPORTS (2012)
A Novel Transcription Complex That Selectively Modulates Apoptosis of Breast Cancer Cells through Regulation of FASTKD2
Kay T. Yeung et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Interferon Regulatory Factor 2 Binding Protein 2 Is a New NFAT1 Partner and Represses Its Transcriptional Activity
Flavia R. G. Carneiro et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Identification of a Phosphorylation-Dependent Nuclear Localization Motif in Interferon Regulatory Factor 2 Binding Protein 2
Allen C. T. Teng et al.
PLOS ONE (2011)
IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression
Allen C. T. Teng et al.
FASEB JOURNAL (2010)
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance
Simona Blotta et al.
BLOOD (2009)
Identification of a Novel Pathway That Selectively Modulates Apoptosis of Breast Cancer Cells
Alexander A. Tinnikov et al.
CANCER RESEARCH (2009)
The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response
Max Koeppel et al.
NUCLEIC ACIDS RESEARCH (2009)
NFAT proteins: emerging roles in cancer progression
Maria Mancini et al.
NATURE REVIEWS CANCER (2009)
Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth
Sandra Ryeom et al.
CANCER CELL (2008)
Regulation of the actin cytoskeleton in cancer cell migration and invasion
Hideki Yamaguchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Angiogenesis in cancer
Naoyo Nishida et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
Identification of novel co-repressor molecules for Interferon Regulatory Factor-2
KS Childs et al.
NUCLEIC ACIDS RESEARCH (2003)
The role of NFAT transcription factors in integrin-mediated carcinoma invasion
S Jauliac et al.
NATURE CELL BIOLOGY (2002)
To cycle or not to cycle: A critical decision in cancer
M Malumbres et al.
NATURE REVIEWS CANCER (2001)
Share Paper
